@Facebook が予防医療に進出 App上で血圧、コレステロール、HPV、マンモグラフィーなどの検査・受診をalertする仕組み 20億人以上のAMUにリーチできる可能性 https://t.co/Z6D4O8nyN7 | @MobiHealthNews
RT @keita_masui: @Facebook が3つの疾患の疫学分布をリアルタイムでマッピングするツールを上市 https://t.co/S30morNbzL | @MobiHealthNews #SNS 内の #bigdata をベースとした #RWE や #epi…
RT @keita_masui: @Facebook が3つの疾患の疫学分布をリアルタイムでマッピングするツールを上市 https://t.co/S30morNbzL | @MobiHealthNews #SNS 内の #bigdata をベースとした #RWE や #epi…
こういう疾患のリアルタイム疫学分布ってMetabiotaがやってなかったっけ?元データをどうやって取ってくるのか、それによってモデリングの精度がどの程度変わるのかが気になる。
#GAFA #FAMGA の #HealthCare の取り組み 実は @Google は過去にGoogleHealthで失敗しています https://t.co/yVyHUVoqP9 GoogleHealthを率いていた @rzeiger 氏は自ら創設した @smart_patients 社を離れて @Facebook のHealthcareのチームに参画 https://t.co/3S4uyMlxkt 今後の展開に着目です
@Facebook が3つの疾患の疫学分布をリアルタイムでマッピングするツールを上市 https://t.co/S30morNbzL | @MobiHealthNews #SNS 内の #bigdata をベースとした #RWE や #epidemiology の進化は筋が良いと思います [参考] @GSK のSNSを用いた安全性調査 https://t.co/SbYXB818TB #FAMGA
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
Articles on developing machine learning - using social digital media (SDM) as a data source for #pharmacovigilance activities
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @DrugSafetyJ: Our Top 3 articles of all times by @altmetric 1. https://t.co/zSNQIJ1jvt (@RebeccaChandle1 et al.) 2. https://t.co/WUkwjVn…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
RT @UMCGlobalSafety: The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluste…
The all-time most read article in @DrugSafetyJ is "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase" by UMC's Dr @RebeccaChandle1 et al. Click the link in the Tweet below to read the paper! #pharmacovigil
RT @DrugSafetyJ: Our Top 3 articles of all times by @altmetric 1. https://t.co/zSNQIJ1jvt (@RebeccaChandle1 et al.) 2. https://t.co/WUkwjVn…
Our Top 3 articles of all times by @altmetric 1. https://t.co/zSNQIJ1jvt (@RebeccaChandle1 et al.) 2. https://t.co/WUkwjVnAe3 (@nabarund et al.) 3. https://t.co/KUtTsVvbll (@sujanucsc et al.) https://t.co/ouJe8AoOYX
ありがとうございます!「ウェアラブルを通じたモニタリング」は「スマホを通じた収集」と比較すると、データ獲得がより確実になるので有望、という示唆かもしれません。例えばGSKのSNSを通じた副作用情報収集の取り組み、Tweet入力頻度のバラつきが課題となっている模様です https://t.co/wcWsZPjhkF
Big Pharma surveils social media, forums for market research & advertising: https://t.co/NgRgpk9rvn https://t.co/YQjOxpVg7T https://t.co/llnxPeiJiW #psychology
@InfinoMe @ethanjweiss FB data has potential in improving drug safety https://t.co/0Tt3AoQofw
RT @ManeeshJuneja: @Grady_Booch I've been told that FB is the largest repository for Adverse Drug Reactions (side effects) https://t.co/eRj…
RT @ManeeshJuneja: @Grady_Booch I've been told that FB is the largest repository for Adverse Drug Reactions (side effects) https://t.co/eRj…
@Grady_Booch I've been told that FB is the largest repository for Adverse Drug Reactions (side effects) https://t.co/eRjvHgtLVY
RT @zakkohane: Time to harness social media efficiently and accurately for drug safety monitoring? https://t.co/YcvEFNDyOO @twitter @facebo…
Time to harness social media efficiently and accurately for drug safety monitoring? https://t.co/YcvEFNDyOO @twitter @facebook #MEDRA
RT @soler_kike: Las redes sociales como herramienta de Farmacovigilancia. https://t.co/dpUH3cWf7D
Mètode per analitzar les #XarxesSocials i extreure dades útils x la #farmacovigilancia En: Drug Saf 2016 May;39:443 https://t.co/N6zfOf3FfH
RT @bibliotecasalut: Les #xarxessocials com a eina de #farmacovigilància ? En: Drug Saf. 2016 May;39:443-54 https://t.co/N6zfOf3FfH
RT @bibliotecasalut: Les #xarxessocials com a eina de #farmacovigilància ? En: Drug Saf. 2016 May;39:443-54 https://t.co/N6zfOf3FfH
Les #xarxessocials com a eina de #farmacovigilància ? En: Drug Saf. 2016 May;39:443-54 https://t.co/N6zfOf3FfH
Trending: Exploring the use of Twitter & Facebook for #pharmacovigilance. A very useful research study. https://t.co/nJsiKBB0Pi #DigitalHea…
RT @ManeeshJuneja: Exploring the use of Twitter & Facebook for #pharmacovigilance. A very useful research study. https://t.co/eRjvHgtLVY #D…
Exploring the use of Twitter & Facebook for #pharmacovigilance. A very useful research study. https://t.co/eRjvHgtLVY #DigitalHealth
Social Media Listening for Routine Post-Marketing Rx Safety Surveillance https://t.co/RGUqkEALq6 HT @GSK
【Drug Safety】 Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/vVAwcpUhfG
RT @epidemico: Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/N5UwHkCe9J @GSK @carrie_pierce @nabarund …
RT @epidemico: Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/N5UwHkCe9J @GSK @carrie_pierce @nabarund …
Social Media Listening for Routine Post-Marketing Rx Safety Surveillance https://t.co/RGUqkEALq6 HT @GSK
RT @epidemico: Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/N5UwHkCe9J @GSK @carrie_pierce @nabarund …
RT @epidemico: Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/N5UwHkCe9J @GSK @carrie_pierce @nabarund …
Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/N5UwHkCe9J @GSK @carrie_pierce @nabarund @heidigbell
Social Media Listening for Routine Post-Marketing Safety Surveillance https://t.co/f4AXuQ7O02 #PtSafety
RT @internetmedassn: Social Media Listening for Routine Post-Marketing Safety Surveillance. https://t.co/4GZz0ph1TH
RT @internetmedassn: Social Media Listening for Routine Post-Marketing Safety Surveillance. https://t.co/4GZz0ph1TH
Social Media Listening for Routine Post-Marketing Safety Surveillance. https://t.co/4GZz0ph1TH
Social Media Listening for Routine Post-Marketing Safety Surveillance. https://t.co/yJS4rfciuO